Filter
565
Text search:
National
Department
of
Health
(Republic
of
South
Africa)
Featured
Recommendations
55
New Publications
140
Language
Document type
No document type
308
Studies & Reports
129
Guidelines
67
Strategic & Response Plan
24
Manuals
23
Training Material
5
Situation Updates
5
Fact sheets
2
App
1
Resource Platforms
1
Countries / Regions
Global
40
South Africa
39
Kenya
18
Nigeria
14
Malawi
14
Uganda
13
Tanzania
12
Africa
12
Ethiopia
11
Zambia
11
Liberia
10
Congo, Democratic Republic of
9
Rwanda
9
Sierra Leone
8
South Sudan
7
Guinea
5
Ghana
5
Myanmar / Burma
5
East and Southern Africa
5
Latin America and the Carribbean
5
Western and Central Europe
5
Asia
5
Cameroon
4
Mozambique
4
Namibia
4
West and Central Africa
4
Haiti
3
Philippines
3
India
3
Bangladesh
3
Sudan
3
Lesotho
3
Middle East and North Africa
3
South–East Asia Region
3
Zimbabwe
2
Syria
2
Chad
2
Central African Republic
2
Eswatini/ Swaziland
2
Brazil
2
Eastern Europe and Central Asia
2
Venezuela
2
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Togo
1
Nepal
1
Afghanistan
1
Germany
1
Turkey
1
Egypt
1
Cambodia
1
Thailand
1
Benin
1
Burundi
1
Ukraine
1
Colombia
1
Angola
1
Sri Lanka
1
Yemen
1
Albania
1
Tajikistan
1
Russia
1
Vietnam
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
177
Clinical Guidelines
52
Women & Child Health
38
Public Health
35
Key Resources
29
Pharmacy & Technologies
9
Capacity Building
7
Toolboxes
HIV
68
Mental Health
40
COVID-19
34
TB
26
Disability
25
Planetary Health
25
AMR
17
NTDs
17
Ebola & Marburg
16
Conflict
16
Global Health Education
14
Refugee
13
Caregiver
12
Health Financing Toolbox
12
Pharmacy
10
Rapid Response
9
Natural Hazards
8
NCDs
6
Zika
5
Malaria
5
2.0 Rapid Response
5
Cholera
3
Social Ethics
3
Polio
2
Typhoon
1
Specific Hazards
1
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in develop
...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk
...
This document is part of the process for improving the quality of care in family planning. Medical eligibility criteria for contraceptive use (MEC), the first edition
...
Burden of T. solium: Neurocysticercosis is a disease induced by T. solium larvae penetrating human tissues, especially the nervous system. Neurocysticercosis burdens economies, societies and individuals because
...
Working document from an informal consultation of experts. A Protocol for risk assessment at the field level. The purpose of document is to provide guidance on the methodology to be used for assess
...
Bulletin of the World Health Organization 2007;85:637–643
Une traduction en français de ce résumé figure à la fin de l’article.
Al final del artículo se facilita una traducción al esp
...
Preliminary overview of refugees and migrants self-reported impact of COVID-19
The study surveyed over 30,000 refugees and migrants living in 170 countries. Many
...
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment
...
The global burden of disease associated with air pollution exposure exacts a massive toll on human health worldwide: exposure to air pollution is estimated to cause millions
...
Against this background of nearly 20 years of experience of research, development and
improvement in patient safety, the role
...
The second edition of the joint WHO, WIPO and WTO
publication “Promoting Access to Medical Technologies
and Innovation: Intersections between public health,
intellectual pro
...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform pra
...
Evidence-based psychological interventions are an important part of health, social, protection and education services and can help increase access to effective mental
...
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significa
...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middl
...
In the mid-1980s, recognizing the limitations of traditional training and that the knowledge and skills acquired are not necessarily applied back in the workplace, MSH developed the Monitoring‐Training-Planning (MTP) approach to assist the Ecuador
...
Evidence from a systematic review on antenatal zinc supplementation was evaluated as part of the World Health Organization (WHO) antenatal care (ANC) guideline development process in 2016, and the f
...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are respo
...
